<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8761FABE-A3A8-4C19-B203-72A81D74E4B0"><gtr:id>8761FABE-A3A8-4C19-B203-72A81D74E4B0</gtr:id><gtr:name>Systagenix Wound Management, Limited</gtr:name><gtr:address><gtr:line1>2 CITY PLACE , BEEHIVE RING ROAD</gtr:line1><gtr:city>GATWICK AIRPORT</gtr:city><gtr:postCode>RH6 0PA</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8761FABE-A3A8-4C19-B203-72A81D74E4B0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>8761FABE-A3A8-4C19-B203-72A81D74E4B0</gtr:id><gtr:name>Systagenix Wound Management, Limited</gtr:name><gtr:address><gtr:line1>2 CITY PLACE , BEEHIVE RING ROAD</gtr:line1><gtr:city>GATWICK AIRPORT</gtr:city><gtr:postCode>RH6 0PA</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>522721.0</gtr:offerGrant><gtr:projectCost>2090884.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=170031"><gtr:id>7331D2D0-A217-465F-948A-8A9273741F7F</gtr:id><gtr:title>Active Wound Healing</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Legacy RDA Dollaborative R&amp;D</gtr:grantCategory><gtr:grantReference>170031</gtr:grantReference><gtr:abstractText>Chronic wounds affect l-2% of the population and present a significant financial
burden to healthcare authorities. In the UK alone it has been estimated to cost the
NHS &amp;pound;1 billion per annum. This cost is expected to rise as both the incidence and
prevalence of chronic wounds is increasing due to a growing elderly and obese
population. The standard of care for the treatment of chronic wounds has moved from
absorbent traditional dressings to more efficacious advanced products that offer better
clinical outcomes. However, clinical studies with these active products have shown a
variable outcome suggesting that all chronic wounds are not equal and that there are
variances in the underlying biochemistry, which controls the healing process.
We have analysed wound fluids from over 200 patients with chronic wounds to
understand the pathophysiology and identify biochemical deficiencies in these
wounds. Our results indicate that within a patient population there are two subgroups,
those that respond well to our products and achieve complete wound closure, and
those for whom our products are ineffective. By analysing the wound fluids from
patients who responded and comparing with those that did not heal, we have identified
that an excessive level of inflammation exists in the wound environment of
non-healing patients.
The objective of this project is to develop a new active therapy, which will address
this defect, resulting in a higher number of wounds healed.</gtr:abstractText><gtr:fund><gtr:end>2011-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>522721</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">170031</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>